Topotecan and Melphalan for Retinoblastoma
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorSun Yat-sen University
About this trial
The purpose of this study is to evaluate topotecan and melphalan for retinoblastoma patients.
Eligibility criteria
Qualifiers
diagnosed as retinoblastoma
receiving eyeball-sparing treatment
Disqualifiers
disease progression during follow-up
Trial design
Treatments tested in this trial
- Topotecan
- Melphalan
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov